MCMichael Cruz Caliz

Michael Cruz Caliz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michael Cruz Caliz has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Christian Castillo Latorre

    Division of Pulmonary, Critical Care & Sleep Medicine, Department of Medicine, University of Miami Leonard Miller School of Medicine, Miami, USA

    2 shared publications
  • Aixa Dones Rodríguez

    San Juan City Hospital, Pulmonary and Critical Care Medicine Fellowship Program, San Juan, Puerto Rico

    1 shared publication
  • Gustavo Gonzalez

    Department of Pulmonary and Critical Care, San Juan City Hospital, San Juan, PR

    1 shared publication
  • Iván González-Cancel

    Centro Cardiovascular de Puerto Rico y del Caribe, Department of Cardiovascular Surgery, San Juan, Puerto Rico

    1 shared publication
  • John Pagán

    Centro Cardiovascular de Puerto Rico y del Caribe, Department of Plastic Surgery, San Juan, Puerto Rico

    1 shared publication
  • Jose Adorno

    Department of Pulmonary and Critical Care, San Juan City Hospital, San Juan, PR

    1 shared publication

Latest Publications

  • Open Access

    Resection and primary reconstruction of a massive chest wall chondrosarcoma

    by Michael J Cruz Caliz, Modesto González-Del Rosario, Iván González-Cancel, Ricardo Fernández González, John Pagán, Christian Castillo Latorre, Juan M García Puebla, Aixa Dones Rodríguez

    Primary malignant tumours of the chest wall are among the rarest cartilaginous tumours. Chondrosarcomas present a difficult clinical problem due to its high resistance to conventional chemotherapy and radiotherapy. Complete surgical resection has been the cornerstone for treatment. It has been associated with better prognosis, survival and less recurrence in contrast to other methods of therapy. Patients with chondrosarcomas generally have a good prognosis when surgical resection is performed. Improvement in outcomes is seen when patients are evaluated in a multidisciplinary care facility. We present the case of a 66-year-old male patient that exhibits a chest wall mass diagnosed as a chondrosarcoma. After chemotherapy failure, our patient was successfully treated with complete surgical excision of the mass. Final tissue biopsy report was remarkable for a p53 gene mutation, which is known to be associated with tumour progression and loss of growth control.


  • Open Access

    Life-threatening hemoptysis: case of Osler–Weber–Rendu Syndrome

    by Ricardo Alicea-Guevara, Michael Cruz Caliz, Jose Adorno, Ricardo Fernandez, Kelvin Rivera, Gustavo Gonzalez, Ricardo Alan Hernandez-Castillo, Rosangela Fernandez, Christian Castillo Latorre

    Hereditary haemorrhagic telangiectasia (HHT), also known as Osler–Weber–Rendu syndrome, is a rare autosomal dominant vascular disorder. Patients with HHT may present with a wide spectrum of clinical manifestations, some considered to be life-threatening. We present the case of a 53-year-old male who presented with massive haemoptysis. Chest computed tomography scan was remarkable for a large anterior, left lower lobe arteriovenous malformation. The patient underwent a pulmonary angiogram with embolization of a large left lung arteriovenous malformation, which proved to be successful in controlling the bleeding.